Search results

Selected filters:

News
Litigation

Article type

Topic

Sector

Regions

Year

416 results found for your search

Sort options
30 November 2018

How a Chinese court would have decided the <em>Unwired Planet</em> appeal

Previous FRAND-related rulings indicate judges in China could set a global rate, would adopt the hard-edged non-discrimination obligation and would consider the parties' negotiation behaviours when reaching their decisions 

30 November 2018

Time is running out to nominate the world’s leading IP strategists

There is not much time left to make nominations for the 2019 edition of IAM Strategy 300, our exclusive guide on the world's best IP strategists.

29 November 2018

OPINION: It's time to sort out the connected car disconnect

TCL v Ericsson and Unwired Planet v Huawei send two very different messages to auto companies being approached by patent pools such as Avanci to take SEP licences, says Unified Patents' chief IP counsel Jonathan Stroud 

26 November 2018

Pharma patent owners in the US are under pressure like they have never been before

Life sciences IP is on the front line as American consumers, legislators and the Trump administration kick back against the high cost of medicines. Reform campaigners say they have never been more confident of change.

25 November 2018

Patent sales on the rise; Microsoft’s deal with Chinese drone company; a deep dive into Oppo’s portfolio; IP insurance goes mainstream; and much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

23 November 2018

Brokered patent sales are on the up as more buyers get active

Exclusive analysis done by ROL Group for IAM shows a maturing market in which prices are stabilising, selling programmes are becoming more streamlined and there are more transactions overall

19 November 2018

Dosage patents come under scrutiny at UK Supreme Court

Justices today considering a much-anticipated case whose outcome could make it harder for pharma companies to obtain such protection in the future

15 November 2018

Congress needs role in key patent reform debates, says senior GOP legislator

Tipped to be the ranking Republican on the House Judiciary Committee, Doug Collins looks set to emerge as one of most powerful IP policy voices on Capitol Hill

15 November 2018

Jury still out on foreign NPEs in China

Firms like iPEL are creating a buzz in the country's patent market, but as of yet there are few indications that Beijing will roll out the welcome mat

15 November 2018

The big life sciences IP developments from October 2018

Cannabis patent war looming, “New NAFTA” set to benefit biopharma innovators, a blow for medical device inventors at the CJEU, and much more in this round-up of October’s big life sciences IP news

14 November 2018

UK Supreme Court rejects Warner-Lambert’s pregabalin appeal

Company now faces possibility of £500 million pay-out to the NHS, while ruling could also make second medical use patents harder to obtain and easier to invalidate

10 November 2018

Acting US Attorney General sat on board of Florida company that ran patent filing scam

Matthew Whitaker (right) allegedly sent intimidating emails to victims of World Patent Marketing, a firm that was shut down by the FTC and fined $26 million for cheating inventors.

02 November 2018

Chinese chipmaker and Taiwan partner hit with US criminal indictments for IP theft

Days after Trump administration slaps Fujian Jinhua with harsh sanctions, the DOJ announces criminal espionage case carrying penalties of up to $20 billion.

01 November 2018

Soon-to-be-released USPTO examination guidance looks like being good news for applicants

Changes on patent eligible subject matter will lead to fewer 101 rejections, says the agency's Silicon Valley chief at IAM's Software IP event in San Francisco

30 October 2018

What every SEP owner and licensee needs to know about the <em>Unwired Planet</em> decision

In upholding the first instance judgment of Mr Justice Birss last week, the Court of Appeals in London has confirmed the UK as a go-to jurisdiction for FRAND-related disputes